Our team is diverse in every respect, spanning geography, generations, and deep expertise.

Jun Deng

Investment Partner

As the first Investment Partner to join the Joyance team, Jun was instrumental in shaping the fund's vision, and now leads healthcare and biotech investment. A PhD by training, she is passionate about translating innovative science to the benefit of human life, and has over a decade of VC experience. This versatile background gives her deep expertise in MedTech, Healthcare, Consumer, and Biotechnology investment, with a global perspective and a diverse portfolio across North America, Europe, and Asia. Jun has led multiple successful exits, including Volumetric (acquired by 3D System), Osmosis (acquired by Reed Elsevier), and Loop Genomics (acquired by Element Biosciences). Jun has supported some of the most visionary and transformative companies in the biotech industry, such as Mission Bio and Ginkgo Bioworks. She has served on the board of various healthcare companies and shares her insights with aspiring entrepreneurs at Singularity University, Endless Frontier Labs of NYU, and BioDesign of Stanford. Outside of work, Jun enjoys exploring nature around the SF-Bay Area, cooking, and experimenting with growing her own vegetables.